Trial Profile
National, Open-label, Multicentre Phase I-II Study of Combination R-ESHAP With Lenalidomide as Salvage Therapy for Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma Candidates to Stem-cell Transplantation
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 02 Aug 2022
Price :
$35
*
At a glance
- Drugs Lenalidomide (Primary) ; Cisplatin; Cytarabine; Etoposide; Methylprednisolone; Rituximab
- Indications Diffuse large B cell lymphoma
- Focus Adverse reactions; Therapeutic Use
- 20 Feb 2019 Status changed from active, no longer recruiting to completed.
- 06 Dec 2016 Preliminary results of the phase 2 (n=44) presented at the 58th Annual Meeting and Exposition of the American Society of Hematology
- 25 Aug 2016 Planned End Date changed from 1 May 2019 to 1 Sep 2019.